You have selected the view in French
Descriptor English: | Insulin | ||||
Descriptor Spanish: |
Insulina
| ||||
Descriptor Portuguese: | Insulina | ||||
Descriptor French: | Insuline | ||||
Entry term(s): |
Chaine A de l'insuline Chaine B de l'insuline Chaîne A de l'insuline Chaîne B de l'insuline Iletin Insuline ordinaire Insuline soluble Novolin |
||||
Tree number(s): |
D06.472.699.587.200.500.625 D12.644.548.586.200.500.625 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D007328 | ||||
Scope note: | A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). |
||||
Annotation: | /blood: consider also HYPERINSULINEMIA (excessively high blood insulin levels) but do not confuse with HYPERINSULINISM (excessive secretion of insulin by pancreas); /immunology: consider also INSULIN ANTIBODIES; precursor = PROINSULIN; INSULIN INFUSION SYSTEMS is available |
||||
Allowable Qualifiers: |
AA analogues et dérivés AD administration et posologie AE effets indésirables AG agonistes AN analyse BI biosynthèse BL sang CF liquide cérébrospinal CH composition chimique CL classification CS synthèse chimique DF déficit EC économie GE génétique HI histoire IM immunologie IP isolement et purification ME métabolisme PD pharmacologie PH physiologie PK pharmacocinétique PO intoxication RE effets des radiations SD ressources et distribution ST normes TO toxicité TU usage thérapeutique UR urine |
||||
Entry Combination: |
antagonists & inhibitors:Insulin Antagonists
|
||||
Pharm Action: |
Hypoglycemic Agents |
||||
Related: |
Activité de type insulinique non suppressible
MeSH Hyperinsulinisme MeSH Proinsuline MeSH Récepteur à l'insuline MeSH | ||||
DeCS ID: | 7500 | ||||
Unique ID: | D007328 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1966/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2011/06/24 |
-
-
PRODUITS CHIMIQUES ET PHARMACEUTIQUES
Hormones, substituts d'hormones et antagonistes d'hormones [D06]Hormones, substituts d'hormones et antagonistes d'hormones -
PRODUITS CHIMIQUES ET PHARMACEUTIQUES
Acides aminés, peptides et protéines [D12]Acides aminés, peptides et protéines
|
Insuline
- Preferred
Chaine A de l'insuline
- Narrower
Novolin
- Narrower
Iletin
- Narrower
Chaine B de l'insuline
- Narrower
Concept UI |
M0011417 |
Preferred term | Insuline |
Entry term(s) |
Insuline ordinaire Insuline soluble |
Concept UI |
M0011418 |
Preferred term | Chaine A de l'insuline |
Entry term(s) |
Chaîne A de l'insuline |
Concept UI |
M0011420 |
Preferred term | Novolin |
Concept UI |
M0011416 |
Preferred term | Iletin |
Concept UI |
M0557300 |
Preferred term | Chaine B de l'insuline |
Entry term(s) |
Chaîne B de l'insuline |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey